DEA DEA Diversion Control 3

Question 1

Which of the following is an example of 'prescription fraud' as investigated by DEA Diversion?

Accepted Answer

Forging or altering a prescription to obtain a controlled substance

Answer

Prescription fraud includes forging, altering, or counterfeiting prescriptions, as well as impersonating practitioners or patients to obtain controlled substances.

Question 2

DEA Form 41 is used by registrants to document:

Accepted Answer

The destruction of controlled substances

Answer

DEA Form 41 (Registrant Record of Controlled Substances Destroyed) is required when a registrant destroys controlled substances, ensuring accountability for all substances removed from commerce.

Question 3

What is the '21 C.F.R. Part 1306' commonly known as in pharmacy and diversion enforcement?

Accepted Answer

The DEA prescription regulations governing valid prescriptions for controlled substances

Answer

21 C.F.R. Part 1306 establishes the federal requirements for valid controlled substance prescriptions, including who may prescribe, what a prescription must contain, and dispensing rules.

Question 4

What is 'diversion through overprescribing' and why is it a criminal offense for physicians?

Accepted Answer

Prescribing controlled substances outside the usual course of professional practice without legitimate medical purpose, which is distribution under the CSA

Answer

When a physician prescribes controlled substances without a legitimate medical purpose, DEA treats them as a drug distributor rather than a practitioner, making them subject to drug trafficking charges.

Question 5

What is the primary purpose of DEA's 'Suspicious Order' requirement for distributors under 21 C.F.R. § 1301.74(b)?

Accepted Answer

To require distributors to report and halt unusually large, frequent, or deviating orders before shipping them, preventing bulk diversion

Answer

The suspicious order rule obligates distributors to identify and report to DEA any order that is unusual in size, frequency, or deviates substantially from normal buying patterns, serving as a key anti-diversion safeguard.

Drug Enforcement Administration (DEA) Practice Test

Drug Enforcement Administration (DEA) Practice Test

DEA DEA Diversion Control 3